Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) was up 5.6% during mid-day trading on Monday . The stock traded as high as $1.32 and last traded at $1.32. Approximately 1,937,451 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 8,164,486 shares. The stock had previously closed at $1.25.
Clover Health Investments Stock Performance
The stock has a market cap of $630.48 million, a P/E ratio of -3.74 and a beta of 2.09. The company's 50 day moving average price is $0.91 and its 200-day moving average price is $0.90.
Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.02. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. The firm had revenue of $346.92 million during the quarter, compared to analyst estimates of $316.10 million. On average, analysts forecast that Clover Health Investments, Corp. will post -0.21 earnings per share for the current fiscal year.
Institutional Trading of Clover Health Investments
Several institutional investors have recently made changes to their positions in CLOV. Swiss National Bank grew its position in Clover Health Investments by 1.6% during the third quarter. Swiss National Bank now owns 782,200 shares of the company's stock valued at $845,000 after buying an additional 12,400 shares during the period. Jump Financial LLC bought a new position in Clover Health Investments during the fourth quarter valued at about $125,000. Citigroup Inc. grew its position in Clover Health Investments by 4,040.8% during the third quarter. Citigroup Inc. now owns 372,421 shares of the company's stock valued at $402,000 after buying an additional 363,427 shares during the period. Turtle Creek Wealth Advisors LLC bought a new position in Clover Health Investments during the fourth quarter valued at about $162,000. Finally, SignalPoint Asset Management LLC grew its position in Clover Health Investments by 40.3% during the first quarter. SignalPoint Asset Management LLC now owns 139,366 shares of the company's stock valued at $111,000 after buying an additional 40,000 shares during the period. Institutional investors own 19.77% of the company's stock.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Further Reading
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
